Pharmacogenetics: Not Quite Ready for Prime Time?

Pharmacogenetics: Not Quite Ready for Prime Time?

https://www.thecarlatreport.com/podcast/pharmacogenetics-not-quite-ready-for-prime-time-2/

Clinicians are inundated with ads for genetic testing, but is genetic testing currently helpful for informing clinical care? The latest issue of The Carlat Child Psychiatry Report includes an interview with Dr. Aaron Besterman, who’s an adult and child & adolescent psychiatrist at the Rady Children’s Hospital inpatient child and adolescent unit in San Diego. He also conducts psychiatric genetic research as a clinical investigator at the Rady Children’s Institute for Genomic Medicine. In our interview with Dr. Besterman, he broke down the current state of genetic research in psychiatry, explaining how these genetic tests work, and what can be reliably taken away from them. Mara and I will discuss the highlights from our interview with Dr. Besterman in this episode.

 

Author
Joshua Feder, M.D. Dr. Feder's Blog

You Might Also Enjoy...

How Effective is Atomoxetine in Children and Adolescents?

Since its FDA approval in 2002, Atomoxetine (brand name Strattera) has become a second or third line option (after stimulants and sometimes after central alpha agonists) for ADHD in both children and adults. Does it work? Listen and find out!

Discussing Stimulant Treatment with Parents

ADHD is one of the most treatable conditions in psychiatry if patients adhere to medication regimens. So, why are parents so resistant to stimulant medications and how can we approach these misconceptions?

Treating Children of Divorce

Each year in the US, there are about 1.04 million divorces, affecting about 800,000 children. How can we navigate the complexities of treating a child with divorce?